BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 25017523)

  • 1. Skin barrier and immune dysregulation in atopic dermatitis: an evolving story with important clinical implications.
    Czarnowicki T; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol Pract; 2014; 2(4):371-9; quiz 380-1. PubMed ID: 25017523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.
    Suárez-Fariñas M; Dhingra N; Gittler J; Shemer A; Cardinale I; de Guzman Strong C; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2013 Aug; 132(2):361-70. PubMed ID: 23777851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.
    Brunner PM; Guttman-Yassky E; Leung DY
    J Allergy Clin Immunol; 2017 Apr; 139(4S):S65-S76. PubMed ID: 28390479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profile of skin barrier proteins and cytokines in adults with atopic dermatitis.
    Orfali RL; Zaniboni MC; Aoki V
    G Ital Dermatol Venereol; 2017 Apr; 152(2):140-147. PubMed ID: 27982552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into T cells and their signature cytokines in atopic dermatitis.
    Wang AX; Xu Landén N
    IUBMB Life; 2015 Aug; 67(8):601-10. PubMed ID: 26178387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The research for atopic dermatitis: up to date].
    Yokozeki H
    Nihon Rinsho; 2014 Aug; 72(8):1503-9. PubMed ID: 25167760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A group of atopic dermatitis without IgE elevation or barrier impairment shows a high Th1 frequency: possible immunological state of the intrinsic type.
    Kabashima-Kubo R; Nakamura M; Sakabe J; Sugita K; Hino R; Mori T; Kobayashi M; Bito T; Kabashima K; Ogasawara K; Nomura Y; Nomura T; Akiyama M; Shimizu H; Tokura Y
    J Dermatol Sci; 2012 Jul; 67(1):37-43. PubMed ID: 22591815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New pathogenic and therapeutic paradigms in atopic dermatitis.
    Malajian D; Guttman-Yassky E
    Cytokine; 2015 Jun; 73(2):311-8. PubMed ID: 25542094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization.
    Noda S; Suárez-Fariñas M; Ungar B; Kim SJ; de Guzman Strong C; Xu H; Peng X; Estrada YD; Nakajima S; Honda T; Shin JU; Lee H; Krueger JG; Lee KH; Kabashima K; Guttman-Yassky E
    J Allergy Clin Immunol; 2015 Nov; 136(5):1254-64. PubMed ID: 26428954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic aspects of atopic dermatitis.
    Lipozencić J; Pastar Z; Kulisić SM; Pavić I
    Acta Dermatovenerol Croat; 2009; 17(3):226-34. PubMed ID: 19818224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etiopathogenesis of atopic dermatitis--an overview.
    Pastar Z; Lipozencić J; Ljubojević S
    Acta Dermatovenerol Croat; 2005; 13(1):54-62. PubMed ID: 15788148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies.
    Furue M; Chiba T; Tsuji G; Ulzii D; Kido-Nakahara M; Nakahara T; Kadono T
    Allergol Int; 2017 Jul; 66(3):398-403. PubMed ID: 28057434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic therapies in atopic dermatitis: The pipeline.
    Renert-Yuval Y; Guttman-Yassky E
    Clin Dermatol; 2017; 35(4):387-397. PubMed ID: 28709570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and emerging concepts in atopic dermatitis pathogenesis.
    Sullivan M; Silverberg NB
    Clin Dermatol; 2017; 35(4):349-353. PubMed ID: 28709564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines and Epidermal Lipid Abnormalities in Atopic Dermatitis: A Systematic Review.
    Upadhyay PR; Seminario-Vidal L; Abe B; Ghobadi C; Sims JT
    Cells; 2023 Dec; 12(24):. PubMed ID: 38132113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial barrier dysfunctions in atopic dermatitis: a skin-gut-lung model linking microbiome alteration and immune dysregulation.
    Zhu TH; Zhu TR; Tran KA; Sivamani RK; Shi VY
    Br J Dermatol; 2018 Sep; 179(3):570-581. PubMed ID: 29761483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atopic dermatitis and psoriasis: two different immune diseases or one spectrum?
    Guttman-Yassky E; Krueger JG
    Curr Opin Immunol; 2017 Oct; 48():68-73. PubMed ID: 28869867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early-onset pediatric atopic dermatitis is characterized by T
    Brunner PM; Israel A; Zhang N; Leonard A; Wen HC; Huynh T; Tran G; Lyon S; Rodriguez G; Immaneni S; Wagner A; Zheng X; Estrada YD; Xu H; Krueger JG; Paller AS; Guttman-Yassky E
    J Allergy Clin Immunol; 2018 Jun; 141(6):2094-2106. PubMed ID: 29731129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th17 cells and tissue remodeling in atopic and contact dermatitis.
    Simon D; Aeberhard C; Erdemoglu Y; Simon HU
    Allergy; 2014 Jan; 69(1):125-31. PubMed ID: 24372156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march.
    Czarnowicki T; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2017 Jun; 139(6):1723-1734. PubMed ID: 28583445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.